Wave Life Sciences outlines 2026 priorities for obesity drug development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. CRWD
2. AVGO
3. VEEV
4. FIVE
5. PLTR
6. NTSK
7. VRTS
8. SPY
9. AI
10. MDT

Go back to Wave Life Sciences outlines 2026 priorities for obesity drug development
(NASDAQ: WVE) Delayed: 6.23 +0.47 (8.16%)
Previous Close $5.76    52 Week High $38.50 
Open $5.84    52 Week Low $8.95 
Day High $6.24    P/E N/A 
Day Low $5.76    EPS $0.00 
Volume 1,300,242